ACOR Stock Outstanding Shares
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
ShortableNo
OptionableNo
Short Percent Of Outstanding Shares0.65
Short Percent Of Float0.66
Shares Outstanding1.24M
Shares Float1.22M
Shares Short8.10K
Short Ratio1.84
0.66%
Short % of Float0.65%
Short % of Shares OutstandingMarket Insider ACOR
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
Major Holders Summary
0.69% Percentage of Shares held by All Insiders
13.22% Percentage of Shares held by All Institutions
13.31% Percentage of Float held by Institutions
23
Number of Institutions Holding SharesInstitutional Ownership
About 13.22% of ACOR shares are held by financial institutions. BNP PARIBAS ARBITRAGE, SNC is the top corporate investor, holding 7.79K shares valued at $4.01K. A 1.4% stake in Acorda Therapeutics, Inc. is owned by the company. owns - shares valued at -, which translates its holding of N/A of the stake in the company.
ACOR Insiders
Among the ACOR insiders holding of 0.69% of the stake in company, SCOPIA CAPITAL MANAGEMENT LP, 10 percent owner, holds the largest shares of 4.75M. COHEN RON, President and CEO, is the second largest ACOR insider with ownership of 149.76K shares. WASMAN JANE, President, Intl and GC, stands third with possession of 117.42K shares of that stake.
Buying/Selling by Insiders
Frequently Asked Questions
How many institutions own ACOR stock?
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ACOR shares is 23, representing 13.22% of the company's common stock.
Who are the major shareholders selling Acorda Therapeutics, Inc. stock?
N/A, in the last quarter, reduced its stake in ACOR by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the ACOR shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned ACOR shares holding by N/A last quarter which brought its holding to - shares worth -.
Investors who are buying ACOR stock?
As per its latest 13F filing, BNP PARIBAS ARBITRAGE, SNC increased its stake in ACOR by 100% in the last quarter. The institutional holder raised its holding to 7.79 thousand shares having worth more than $4.01K. N/A also added N/A more shares of ACOR to its portfolio, raising its holding to - shares of worth -. N/A also increased its ACOR shares holding by N/A which brought its holding to - shares worth -.
ACOR's major insiders: who are they?
The insider with the most stakes in ACOR is SCOPIA CAPITAL MANAGEMENT LP , 10 percent owner at the company. Additionally, ACOR stock is highly held by President and CEO COHEN RON and President, Intl and GC Wasman Jane among others.
Did an insider recently sell ACOR stock?
Company executives, directors, and other insiders own 0.69% percent of Acorda Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ACOR insiders have sold stock, totaling 0 shares. Insiders that have sold shares include COHEN RON, WASMAN JANE, and SABELLA LAUREN M.
Which insider recently purchased ACOR stock?
There have been 0 transaction(s) during the past 6-months in which Acorda Therapeutics, Inc. insiders have bought stock, totalling 0 shares
How much of ACOR does insiders own?
Around 0 Acorda Therapeutics, Inc. shares are held by insiders, which represents about 0.69% of ACOR stock.
Who is the insider with the largest stake?
ACOR 10 percent owner, SCOPIA CAPITAL MANAGEMENT LP holds the largest portfolio of the company's shares. ACOR shares owned by SCOPIA total nearly 4.75 million.
Which institution holds the most shares in ACOR?
BNP PARIBAS ARBITRAGE, SNC is the largest institutional owner in ACOR which holds 7.79 thousand shares worth $4.01K or 1.4% of the total ACOR shares outstanding followed by N/A with ownership of - shares representing N/A of the ACOR ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.
Is Acorda Therapeutics, Inc. stock optionable?
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ACOR is concerned, it is a stock which is not optionable.
Is there a short position on ACOR's shares?
Number of ACOR shares short is 8.10K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
About how many outstanding ACOR shares are there?
As of today, 1.24M shares of ACOR are outstanding.
Is there many float in ACOR stock?
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ACOR has 1.22M shares in float.
ACOR short ratio: what is it?
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ACOR is 1.84.